Skip to main content

Table 1 Characteristics of people who inject drugs in study sample (n = 33)

From: Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs

 

n (%)*

Socio-demographics

 City

  Boston

16 (48)

  Providence

17 (52)

 Age in years; median (interquartile range; IQR)

36 (32–48)

 Race (categories are not mutually exclusive)

  American Indian or Alaska Native

3 (9)

  Black or African American

7 (21)

  White

22 (67)

  Other

5 (15)

 Ethnicity: Hispanic/Latino

8 (24)

 Gender

  Male

18 (55)

  Female

13 (39)

  Transgender

1 (3)

  Genderqueer

1 (3)

 Sexual orientation

  Heterosexual or “Straight”

21 (64)

  Bisexual

8 (24)

  Homosexual or gay

4 (12)

 Educational attainment

  Less than high school

9 (27)

  High school or GED

13 (39)

  Some college

11 (33)

 Employment status: unemployed

23 (70)

 Health insurance: has public health insurance

32 (97)

Sexual health and behaviors

 HIV testing, past year (n = 32)

30 (93)

 STI testing, past year

24 (73)

 Diagnosed with HCV, ever

26 (79)

  Time since HCV diagnosis in years; median (interquartile range; IQR)

5 (1.5–9)

 Number of sex partners, past 3 months

  0

6 (18)

  1

12 (36)

  2+

17 (45)

 Condom use, past 3 months (vaginal or anal sex; n = 27 with ≥ 1 sex partner)

  Never/rarely

12 (45)

  Sometimes/usually

10 (37)

  Always

5 (19)

Substance use behaviors

 Frequency of drug injection, past 3 months

  Less than once a month

2 (6)

  1 to 3 days a month

2 (6)

  Once a week

1 (3)

  2 to 6 days a week

8 (24)

  Once a day everyday

3 (9)

  2+ times a day everyday

17 (51)

 Drugs injected, past 3 months (not mutually exclusive)

  Heroin

31 (94)

  Prescription opioids

3 (9)

  Methadone

1 (3)

  Cocaine

23 (70)

  Crack

13 (39)

  Crystal methamphetamine

11 (33)

  Cocaine/heroin combination (“Speedball”)

12 (36)

 Current syringe access (not mutually exclusive)

  Needle syringe program (NSP)

27 (82)

  Pharmacy

10 (30)

  Other people

5 (15)

 Any distributive syringe sharing, past month (n = 32)

15 (47)

 Any receptive syringe sharing, past month

19 (57)

 Any distributive or receptive syringe sharing, past month

21 (64)

 Any shared injection paraphernalia (cookers, cottons, rinse water), past month

21 (64)

PrEP knowledge and experience

 Had heard of PrEP prior to study

12 (36)

 Had taken PrEP prior to study

1 (3)

 Perceived change in risk behaviors if taking PrEP in future (n = 32)

  Yes: increase

5 (16)

  Yes: decrease

7 (22)

  No change

20 (63)

 Likelihood of using PrEP in future

  Extremely unlikely

0 (0)

  Unlikely

3 (9)

  Undecided

13 (39)

  Likely

10 (30)

  Extremely likely

7 (21)

  1. *May exceed 100% when categories were not mutually exclusive